Restoration of Treg cell fitness and/or expansion of their numbers using low-dose natural IL-2, the main cytokine driving Treg cell survival and function, has demonstrated clinical efficacy in early clinical trials.
[Nature Reviews Rheumatology]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
168498
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
